Get the Stockscreener App
4.2142
1.54%
-0.0658
Titan Pharmaceuticals Inc De Stock (TTNP) Forecast
The Titan Pharmaceuticals Inc De (TTNP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $9.0168, representing a +113.96% increase from the current price of $4.2142. The highest analyst price target is $9.0947, and the lowest is $8.9389.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TTNP Price Target
Average 11.86
(+181.41% Upside)
Is Titan Pharmaceuticals Inc De (TTNP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.08 | Neutral |
| STOCH(9,6) | 61.83 | Neutral |
| STOCHRSI(14) | 72.87 | Neutral |
| MACD(12,26) | -0.0605 | Sell |
| ADX(14) | 21.01 | Neutral |
| William %R | -40.38 | Neutral |
| CCI(14) | 8.6594 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.2645
Sell
|
4.2859
Sell
|
| MA20 |
4.3623
Sell
|
4.3345
Sell
|
| MA50 |
4.4213
Sell
|
4.3845
Sell
|
| MA100 |
4.4318
Sell
|
4.3422
Sell
|
| MA200 |
4.022
Buy
|
4.4619
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, TTNP could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on TTNP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 46.08 indicates that TTNP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 61.83 indicates that TTNP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 72.87 indicates that TTNP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 21.01 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 8.6594 indicates that TTNP is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term TTNP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Titan Pharmaceuticals Inc De financial reports and earnings history, Titan Pharmaceuticals Inc De (TTNP) stock could reach $12.56 by 2030, $51.02 by 2040 and $68.61 by 2050. See the projected annual prices until 2050 of the Titan Pharmaceuticals Inc De stock below:
- Titan Pharmaceuticals Inc De (TTNP) is expected to reach an average price of $37.14 in 2035, with a high prediction of $37.17 and a low estimate of $36.76. This indicates an $781.35% rise from the last recorded price of $4.2142.
- Titan Pharmaceuticals Inc De (TTNP) stock is projected to chart a bullish course in 2040, with an average price target of $51.02, representing an $1,111% surge from its current level. The forecast ranges from a conservative $50.53 to a sky-high $51.02.
- Our analysts predict Titan Pharmaceuticals Inc De (TTNP) to jump 1,362% by 2045, soaring from $61.00 to an average price of $61.61, potentially reaching $61.69. While $61.00 is the low estimate, the potential upside is significant.
- Titan Pharmaceuticals Inc De (TTNP) stock is expected to climb by 2050, reaching an average of $68.53, a $1,526% jump from its current level. However, a wide range of estimates exists, with high and low targets of $68.61 and $67.86, respectively, highlighting the market's uncertainty.
Titan Pharmaceuticals Inc De Stock (TTNP) Year by Year Forecast
Titan Pharmaceuticals Inc De Stock (TTNP) Price Forecast for 2025
Titan Pharmaceuticals Inc De Stock (TTNP) is expected to reach an average price of $8.2163 in 2025, with a high prediction of $9.5671 and a low estimate of $6.8655. This indicates an +94.97% rise from the last recorded price of $4.2142.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2025 | $9.0541 | $8.9389 | $9.0947 | +114.85% |
| November, 2025 | $9.2308 | $9.1049 | $9.2439 | +119.04% |
| December, 2025 | $9.4567 | $9.2679 | $9.5671 | +124.40% |
Titan Pharmaceuticals Inc De Stock (TTNP) Price Forecast for 2026
The predicted value for Titan Pharmaceuticals Inc De (TTNP) in 2026 is set at an average of $12.12. Estimates vary from a peak of $14.78 to a trough of $9.4606, indicating an +187.60% surge from the present price of $4.2142.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.6943 | $9.4606 | $9.762 | +130.04% |
| February, 2026 | $12.96 | $9.7174 | $13.92 | +207.48% |
| March, 2026 | $13.09 | $12.88 | $13.60 | +210.59% |
| April, 2026 | $14.10 | $12.98 | $14.78 | +234.57% |
| May, 2026 | $13.52 | $12.83 | $14.23 | +220.83% |
| June, 2026 | $13.29 | $13.09 | $13.62 | +215.39% |
| July, 2026 | $13.14 | $12.77 | $13.37 | +211.85% |
| August, 2026 | $13.59 | $13.16 | $13.72 | +222.55% |
| September, 2026 | $13.73 | $13.46 | $14.22 | +225.78% |
| October, 2026 | $13.70 | $13.57 | $13.81 | +225.20% |
| November, 2026 | $13.92 | $13.64 | $14.06 | +230.20% |
| December, 2026 | $13.79 | $13.76 | $14.01 | +227.14% |
Titan Pharmaceuticals Inc De Stock (TTNP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Titan Pharmaceuticals Inc De (TTNP) is $14.84, with a high forecast of $16.03 and a low forecast of $13.65. This indicates an +252.13% increase from the last price of $4.2142.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $13.88 | $13.65 | $14.11 | +229.31% |
| February, 2027 | $13.78 | $13.76 | $14.14 | +226.94% |
| March, 2027 | $13.71 | $13.68 | $13.95 | +225.30% |
| April, 2027 | $13.79 | $13.66 | $14.09 | +227.22% |
| May, 2027 | $14.19 | $13.73 | $14.22 | +236.73% |
| June, 2027 | $14.17 | $14.08 | $14.32 | +236.18% |
| July, 2027 | $14.39 | $14.14 | $14.49 | +241.43% |
| August, 2027 | $14.40 | $14.37 | $14.56 | +241.64% |
| September, 2027 | $14.30 | $14.18 | $14.59 | +239.37% |
| October, 2027 | $14.65 | $14.29 | $14.71 | +247.74% |
| November, 2027 | $15.68 | $14.67 | $15.73 | +271.96% |
| December, 2027 | $15.93 | $15.42 | $16.03 | +277.92% |
Titan Pharmaceuticals Inc De Stock (TTNP) Price Forecast for 2028
In 2028, Titan Pharmaceuticals Inc De (TTNP) is projected to reach an average price of $16.91, with a high projection of $17.93 and a low estimate of $15.90. This indicates an +301.30% rise from the last price of $4.2142.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $16.07 | $15.95 | $16.21 | +281.26% |
| February, 2028 | $16.02 | $15.90 | $16.34 | +280.09% |
| March, 2028 | $16.19 | $16.02 | $16.28 | +284.15% |
| April, 2028 | $16.28 | $16.16 | $16.38 | +286.30% |
| May, 2028 | $16.43 | $16.25 | $16.68 | +289.88% |
| June, 2028 | $16.75 | $16.41 | $16.79 | +297.47% |
| July, 2028 | $17.01 | $16.75 | $17.06 | +303.75% |
| August, 2028 | $17.15 | $17.02 | $17.23 | +307.03% |
| September, 2028 | $17.29 | $17.08 | $17.34 | +310.37% |
| October, 2028 | $17.46 | $17.29 | $17.49 | +314.42% |
| November, 2028 | $17.72 | $17.48 | $17.72 | +320.42% |
| December, 2028 | $17.79 | $17.73 | $17.93 | +322.20% |
Titan Pharmaceuticals Inc De Stock (TTNP) Price Forecast for 2029
The 2029 price forecast for Titan Pharmaceuticals Inc De Stock (TTNP) is $20.05 on average, with a high prediction of $28.54 and a low estimate of $11.56. This represents an +375.83% increase from the previous price of $4.2142.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $18.01 | $17.79 | $18.05 | +327.37% |
| February, 2029 | $18.15 | $17.98 | $18.15 | +330.64% |
| March, 2029 | $18.30 | $18.13 | $18.30 | +334.31% |
| April, 2029 | $18.46 | $18.30 | $18.49 | +338.03% |
| May, 2029 | $18.67 | $18.41 | $18.75 | +343.03% |
| June, 2029 | $18.79 | $18.64 | $18.80 | +345.94% |
| July, 2029 | $19.06 | $18.77 | $19.07 | +352.38% |
| August, 2029 | $24.66 | $19.08 | $27.19 | +485.23% |
| September, 2029 | $26.88 | $24.49 | $27.34 | +537.93% |
| October, 2029 | $26.51 | $25.58 | $28.54 | +529.17% |
| November, 2029 | $26.65 | $26.01 | $28.52 | +532.27% |
| December, 2029 | $11.60 | $11.56 | $26.61 | +175.27% |
Titan Pharmaceuticals Inc De Stock (TTNP) Price Forecast for 2030
Titan Pharmaceuticals Inc De Stock (TTNP) is expected to reach an average price of $13.47 in 2030, with a high forecast of $15.55 and a low forecast of $11.39. This signifies an +219.64% surge from the last price of $4.2142.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $12.04 | $11.39 | $12.56 | +185.76% |
| February, 2030 | $12.21 | $11.95 | $12.36 | +189.83% |
| March, 2030 | $12.16 | $12.12 | $12.53 | +188.50% |
| April, 2030 | $12.22 | $11.93 | $12.35 | +190.02% |
| May, 2030 | $12.81 | $12.26 | $12.90 | +203.95% |
| June, 2030 | $12.89 | $12.67 | $12.94 | +205.85% |
| July, 2030 | $13.37 | $12.98 | $13.37 | +217.23% |
| August, 2030 | $13.79 | $13.46 | $13.80 | +227.20% |
| September, 2030 | $14.34 | $13.90 | $14.40 | +240.38% |
| October, 2030 | $14.76 | $14.40 | $14.78 | +250.14% |
| November, 2030 | $15.13 | $14.80 | $15.26 | +259.11% |
| December, 2030 | $15.54 | $15.23 | $15.55 | +268.73% |
0.10%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):